What's New in Breast Cancer - Susan G. Komen®
What’s New in Breast Cancer. This section gives an overview of new breast cancer treatment breakthroughs and recent developments in research that are fueling new ways to assess risk, and prevent, detect, diagnose and treat breast cancer.
Estrogen a more powerful breast cancer culprit than we realized
May 17, 2023 · Estrogen is already known to fuel breast cancer growth by promoting the proliferation of breast cells. However, the new observations cast this hormone in a different light. They show estrogen is a more central character in cancer genesis because it directly alters how cells repair their DNA.
Breast cancer deaths in the US continue to fall, but new report …
Oct 1, 2024 · Despite a continuous decline in the rate of breast cancer deaths in the United States, the incidence of the disease has increased, especially among younger ages, and significant racial...
New study finds triple-negative breast cancer tumors with an …
Apr 25, 2024 · By Kelley Luckstein. A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
FDA expands approval of breast cancer drug Kisqali to ... - NBC News
Sep 17, 2024 · The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said.
A wearable ultrasound scanner could detect breast cancer earlier
Jul 28, 2023 · In hopes of improving the survival rate for breast cancer patients, MIT researchers designed a wearable ultrasound device that could allow women to detect tumors when they are still in early stages.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
Jun 7, 2022 · Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival. For some patients with metastatic tumors not significantly affected by other forms of chemotherapy, the treatment halted their...
Experimental immunotherapy targets metastatic breast cancer
Feb 1, 2022 · In a clinical trial of 42 women with metastatic breast cancer, 28 (or 67%) generated an immune reaction against their cancer. The approach was used to treat six women, half of whom experienced measurable tumor shrinkage.
WHO launches new roadmap on breast cancer
Feb 3, 2023 · The World Health Organization (WHO) released a new Global Breast Cancer Initiative Framework today providing a roadmap to attain the targets to save 2.5 million lives from breast cancer by 2040.
Enhertu Effective in HER2-Positive Metastatic Breast Cancer
Oct 19, 2021 · In people with metastatic HER2-positive breast cancer, the targeted drug trastuzumab deruxtecan (Enhertu) markedly lengthened progression-free survival compared with trastuzumab emtansine (Kadcycla), new study results show.